Search Results 31-40 of 16118 for Chronic lymphocytic leukaemia
... chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells ... Giving ibrutinib and obinutuzumab with venetoclax may work better at treating ...
... chronic lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL ...
... chronic lymphocytic leukemia or small lymphocytic lymphoma. Ibrutinib may ... chronic lymphocytic leukemia or small lymphocytic lymphoma. Participation ...
... chronic lymphocytic leukemia that has returned or is resistant to treatment. Participation eligibility. Participant eligibility includes age, gender, type ...
Diagnosis of B-cell CLL established according to International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria and documented within medical records.
Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia ...
... chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...
... Chronic Lymphocytic Leukemia. Print details. Share; Facebook · Twitter. Overview ... Diagnosis of Skin Cancer, with or without a CLL diagnosis. Exclusion ...
Giving pembrolizumab alone or with idelalisib or ibrutinib may be an effective treatment in patients with chronic lymphocytic leukemia or other low-grade B-cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.